The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of claudin 18.2 (CLD18.2) in gastric cancers and clinical correlation.
 
Jaspreet Kaur
No Relationships to Disclose
 
Gauri Wagh
No Relationships to Disclose
 
Rohini Patil
No Relationships to Disclose
 
Rajiv Kaushal
No Relationships to Disclose
 
Subhash Yadav
No Relationships to Disclose
 
Anant Ramaswamy
No Relationships to Disclose
 
Prabhat Bhargava
Honoraria - Intas (Inst); Merck (Inst)
Consulting or Advisory Role - Lupin Pharmaceuticals (Inst); Mankind Pharma (Inst)
Speakers' Bureau - Novartis (Inst); Zydus Pharmaceuticals (Inst)
 
Mahesh Khandare
No Relationships to Disclose
 
Vikas Ostwal
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BDR Pharmaceutics (Inst); Cadila Pharmaceuticals (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Lupin Pharmaceuticals (Inst); Merck (Inst); MSD (Inst); NATCO Pharma (Inst); Panacea Pharmaceuticals (Inst); Panacea Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Intas; Merck; NATCO Pharma; NATCO Pharma; PredOmix Technologies Pvt